Recent testing has found that Zantac (also known as ranitidine) contains unsafe levels of the known carcinogen NDMA, or N-nitrosodimethylamine. This has led to a widespread recall by companies that produce the drug, as well as the removal of these products from pharmacy shelves across the nation.
While the product has been pulled from shelves nationwide, the FDA has not issued an official recall, though they stated in the fall of 2019 that they were ordering all Zantac manufacturers to conduct testing for NDMA.
NDMA has been a known cancer risk for decades. An article from the 1970s stated that “NDMA has caused cancer in nearly every laboratory animal tested so far.” It is classified as a probable carcinogen by the US Food and Drug Administration (FDA), Environmental Protection Agency (EPA), World Health Organization (WHO), and the International Agency for Research on Cancer (IARC).
What you should do if you should do if you are currently taking Zantac (Ranitidine)
If you’re currently taking Zantac to treat heartburn, acid reflux, or other symptoms, it is advisable to STOP and contact your doctor to find a safer alternative. If you are a Zantac user who has been diagnosed with cancer, call us to learn your rights regarding compensation.
Zantac users who have been diagnosed with any of the following cancers may be eligible to receive compensation:
Small intestine cancer
In 2018, the FDA recalled a group of blood pressure medications due to tests that showed the drugs were contaminated with “trace levels” of NDMA. This contamination wound up being due to the manufacturing process. In contrast, testing of ranitidine found levels of NDMA that ranged between 250 and 3,000 times the FDA allowable limit. Additionally, research indicates that the NDMA apparent in Zantac samples comes from the instability of its own structure, rather than contamination due to process errors.
How Can We Help?
Zantac was first introduced in 1983 and quickly became one of the best-selling antacids in the nation. Though the drug companies knew about the potentially cancerous properties of NDMA, they did not conduct any tests for the compound nor did they place any warnings about a potential carcinogen on the packaging to alert consumers. Many individuals who suffer from gastric discomfort have been treating their symptoms with the drug for years or even decades. Those unfortunate enough to have developed cancer due to regular and continued use of Zantac or similar drugs are encouraged to seek compensation. Our fierce legal team at Kwartler Manus, LLC can help you win the money you deserve.
If you or a loved one has developed cancer after using Zantac (ranitidine), you aren’t alone. Our dedicated attorneys have experience representing clients in mass tort cases (when a civil wrong is committed by a person, entity, or group which results in injury to many victims). By filing/joining a mass tort claim against Zantac, you may be able to get compensation for your damages and protect others from future threats. Our attorneys will be by your side to help you navigate this complex process with ease.
Don’t hesitate to pursue the compensation you deserve to make up for these pharmaceutical companies’ mistakes. Contact us today to schedule a free consultation and learn your rights.